DOI: https://doi.org/10.22141/2224-0721.2.58.2014.76488

Using Autoantibodies for Differential Diagnosis of Different Types of Diabetes Mellitus (Literature Review)

Ye.V. Globa, N.B. Zelinska

Abstract


The article deals with the definition of specific autoantibodies for differential diagnosis of diabetes mellitus. The characteristic of the types of these autoantibodies and diagnostic methods for their determination are provided.


Keywords


autoantibodies; diabetes mellitus; diagnostics

References


Lebi J., Pruhova S., Dusatkova P. et al. Does continuous targeted medical education increase the rate of referrals for genetic testing for MODY? The Czech experience // Pediatric Diabetes. — 2012. — Vol. 13 (S.17). — P. 32.

Fendler W., Borowiec M., Baranowska-Zazwiecka A. et al. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign — joint epidemiologic report of the PolPedDiab Collаboration and the TEAM Programme // Pediatric Diabetes. — 2012. — Vol. 13 (S.17). — P. 42.

Besser R., Shepherd M., McDonald T. et al. Urinary C-Peptide creatinine ratio is a practical outpatient tool for identifying Hepatocyte Nuclear Factor 1-a/Hepatocyte Nuclear Factor 4-a Maturity-Onset Diabetes of the Young from long-duration type 1 diabetes // Diabetes Care. — 2011. — Vol. 34, № 2. — Р. 286-291.

Ellard S., Bellanné-Chantelot C., Hattersley A. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young // Diabetologia. — 2008.

Shepherd M., Pearson E., Houghton J., Salt G., Ellard S., Hattersley A. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas // Diabetes Care. — 2003. — Vol. 26 (11). — P. 3191-3192.

Global IDF/ISPAD Guideline for diabetes in childhood and adolescence // IDF 2011. — P. 31-37.

Barker J.M., Barriga K.J., Yu L. et al. Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young ­(DAISY) // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 3896-3902.

Ziegler A.G., Rewers M., Simell O. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children // JAMA. — 2013. — Vol. 309. — P. 2473-2479.

Parikka V., Näntö-Salonen K., Saarinen M. et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk // Diabetologia. — 2012. — Vol. 55. — P. 1926-1936.

Vehik K., Fiske S.W., Logan C.A. et al. The TEDDY Study Group. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY // Diabetes Metab. Res. Rev. — 2013. — 29. — 557-567.

Ziegler A.G., Hummel M., Schenker M., Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2 year analysis of the German BABYDIAB Study // Diabetes. — 1999. — Vol. 48. — P. 460-468.

Winter W.E., Harris N., Schatz D. Immunological markers in the diagnosis and prediction of autoimmune type 1 diabetes // Clinical Diabetes. — 2002. — Vol. 20 (4). — P. 183-191.

Hummel M., Bonifacio E., Schmid S., Walter M., Knopff A., Ziegler A.G. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents // Ann. Intern. Med. — 2004. — Vol. 140 (11). — P. 882-6.

Naserke H.E., Bonifacio E., Ziegler A.G. Prevalence, cha-racteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes // J. Clin. Endocrinol. Metab. — 2001. — Vol. 86. — P. 4826-4833.

Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus // Nature. — 1987. — 329. — P. 599-604.

Redondo M.G., Eisenbarth G.S. Genetic control of autoimmunity in type 1 diabetes and associated disorders // Diabetologia. — 2002. — 45. — P. 605-622.

Verge et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies // Diabetes. — 1996. — Vol. 45. — P. 926-933.

Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Chase H.P., Eisenbarth G.S. Number of аutoantibodies (against insulin, GAD or ICA512/IA2) rather then particular autoantibody specificities determines risk of type 1 diabetes // J. Autoimmun. — 1996. — Vol. 9 (3). — Р. 379-383.

Bingley P.J., Gale E.A. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicoti-namide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk // Diabetologia. — 2006. — Vol. 49 (5). — Р. 881-890.

Krischer J.P., Cuthbertson D.D., Yu L., Orban T., Maclaren N., Jackson R. et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes // J. Clin. Endocrinol. Metab. — 2003. — Vol. 88 (1). — P. 103-108.

Heras P., Mantzioros M., Mendrinos D., Heras V., Hatzopoulos A. et al. Autoantibodies in type 1 diabetes // Diabetes Res. Clin. Pract. — 2010. — Vol. 90 (2). — P. 40-42.

Петряйкина Е., Рытикова Н. Диагностика сахарного диабета 1 и 2 типов // Лечащий врач. — 2005. — № 5. — С. 21-24.

Горст К.А. Оценка возможности выявления антител к инсулину методом иммуноферментного анализа: Дипломная работа. — Московский государственный университет им. М.В. Ломоносова. Биологический факультет, кафедра биохимии. Москва, 2010. — 46 с.

Bottazzo G.F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies // Lancet. — 1974. — Vol. 2 (7892). — Р. 1279-83.

Никонова Т.В., Шаповальянц О.С. Диагностическая и прогностическая значимость аутоантител при сахарном диабете. Новый маркер аутоиммунного процесса — антитела к ZnT8 // Сахарный диабет. — 2011. — № 2. — С. 18-22.

Ponsonby A., Pezic A., Cameron F.J., Rodda C., Ellis J.A., Kemp A.S., Carlin J., Dwyer T. Phenotypic and environmental factors associated with elevated autoantibodies at clinical onset of paediatric type 1 diabetes mellitus // Results Immunol. — 2012. — № 2. — P. 125-131.

Palmer J.P., Hampe C., Chiu H., Goel A., Brooks-Worrell B.M. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? // Diabetes. — 2005. — Vol. 54, Suppl. 2. — P. 62-67.

Torii S. Expression and function of IA-2 family proteins, unique neuroendocrine-specific protein-tyrosine phosphatases // Endocr. J. — 2009. — Vol. 56 (5). — Р. 639-648.

Bonifacio E., Lampasona V., Bingley P.J. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens // J. Immunol. — 1998. — Vol. 161 (5). — Р. 2648-2654.

Achenbach P., Warncke K., Reiter J., Naserke H.E. et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics // Diabetes. — 2004. — Vol. 53. — P. 384-392.

Palmer J.P., Asplin C.M., Clemons P. et al. Insulin antibo-dies in insulin-dependent diabetics before insulin treatment // Science. — 1983. — Vol. 222. — Р. 1337-1339.

Mueller P.W., Achenbach P., Lampasona V., Schlosser M., Williams A.J. Type 1 Diabetes Autoantibodies. Prediction and Diagnosis of Autoimmune Diabetes // Clinical Laboratory News. — 2010. — Vol. 36 (10). — P. 8-10.

Achenbach P., Koczwara K, Knopff A., Naserke H., Ziegler A., Bonifacio E. Mature high-affinity immune responses to (pro) insulin anticipate the autoimmune cascade that leads to type 1 diabetes // J. Clin. Invest. — 2004. — Vol. 114(4). — P. 589-597.

Vardi P., Ziegler A., Matthews J.H., Dib S., Keller R., Ricker A. et al. Concentration of insulin autoantibodies at onset of type 1 diabetes. Inverse log-linear correlation with age // Diabetes care. — 1988. — Vol. 11(9). — P. 736-739.

Wenzlau J.M., Juhl K., Yu L., Moua O. et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes // Proceedings of the National Academy of Sciences (U.S.). — 2007. — Vol. 104 (43). — P. 17040-17045.

Wenzlau J.M., Moua O., Sarkar S.A., Yu L., Rewers M., Eisenbarth G.S., Davidson H.W., Hutton J.C. SlC30A8 Is a Major Target of Humoral Autoimmunity in Type 1 Diabetes and a Predictive Marker in Prediabetes // Ann. N. Y. Acad. Sci. — 2008. — Vol. 1150. — P. 256-259.

Achenbach P., Lampasona V., Landherr U. et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk // Diabetologia. — 2009. — Vol. 52. — P. 1881-1888.

Long A., Gooneratne A.T., Rokni S., Williams A.J., Bingley P.J. The Role of Autoantibodies to Zinc Transporter 8 in Prediction of Type 1 Diabetes in Relatives: Lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) Cohort // J. Clin. Endocrinol. Metab. — 2012. — Vol. 97. — P. 632-637.

Lendrum R., Walker G., Gamble D.R. Islet-cell antibodies in juvenile diabetes mellitus of recent onset // Lancet. — 1975. — Vol. 1. — P. 880-882.

Maclaren N.K., Huang S.W., Fogh J. Antibody to cultured human insulinoma cells in insulin-dependent diabetes // Lancet. — 1975. — Vol. 1. — P. 997-1000.

MacCuish A.C., Irvine W.J., Barnes E.W., Duncan L.J. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease // Lancet. — 1974. — Vol. 2. — P. 1529-1531.

Polly J.B., Alistair J.K. Islet Autoantibody Testing: An End to the Trials and Tribulations?// Diabetes. — 2013. — Vol. 62(12). — P. 4009-4011.

Urbanová J., Rypáčková B., Procházková Z., Kučera P., Cerná M., Anděl M, Heneberg P. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level // Diabet Med. — 2013. — Sep 16. doi: 10.1111/dme.12314. [Epub ahead of print].

McDonald T.J., Colclough K., Brown R., Shields B., Shepherd M., Bingley P., Williams A., Hattersley A.T. and Ellard S. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes // Diabet. Med. — 2011. — Vol. 28. — Р. 1028-1033.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта